IO Health, a startup building workflow tools for home healthcare providers, wrapped up 2025 with impressive growth metrics that position the company for a major expansion in 2026. The company hit $1 million in annual recurring revenue, grew its customer base from 2 to 13 organizations, and secured $2 million in seed funding led by Nina Capital.
Breaking Through the Documentation Bottleneck
Healthcare workers spend enormous amounts of time on paperwork. This is especially true in home health and hospice care, where nurses and therapists visit patients in their homes and must document everything to comply with Medicare rules. IO Health CEO recognized this problem during his decade running home health companies and saw an opportunity to build something better.
The company's approach differs from many AI healthcare startups. Rather than trying to replace human workers with automation, IO Health creates a layer of software that sits on top of existing electronic medical record systems. This software provides real time help to clinicians as they work, suggesting documentation improvements and catching compliance issues before they become problems. The system works without requiring expensive integrations with backend systems, which means healthcare organizations can start using it within days rather than months.
The Numbers Tell the Story
Looking at IO Health's Q4 2025 performance reveals strong momentum across multiple metrics. The company ended the year with 532 active clinician users managing care for 6,902 patients. Revenue hit $216,304 for the quarter, representing 42% growth compared to Q3. While the company posted a net loss of $352,192, this aligns with typical early stage growth investing patterns.
Monthly revenue grew steadily throughout 2025, climbing from around $6,000 in January to $85,000 in December. Patient census expanded from under 2,000 at the start of the year to nearly 7,000 by year end. Revenue per patient stabilized around $11 to $12 monthly, suggesting a consistent pricing model that scales with usage.
The company achieved several notable milestones: 100% conversion rate from pilot programs to paying customers, 100% customer retention, and 181% revenue retention (meaning existing customers expanded their usage significantly). These metrics suggest strong product market fit and customer satisfaction.
Product Evolution and Market Expansion
Throughout Q4, IO Health rolled out several new features based on customer feedback. The End of Visit Compliance Check helps ensure documentation meets regulatory requirements before clinicians finish their visits. An improved electronic documentation solution eliminates paper processes, saving approximately 30 minutes per patient admission and $7 in printing costs.
The company also added medication alerts to help providers manage drug costs and compliance, along with AI powered features for contextual lookback and automatic narrative checks. A new distribution system makes it easier for healthcare organizations without mobile device management infrastructure to deploy the software.
In October, IO Health expanded beyond home health into hospice care, landing three paying customers in that segment by year end. This diversification opens up additional market opportunities while leveraging the same core technology platform.
Building the Team for Scale
IO Health grew its team to 25 full time employees by the end of Q4, a 47% increase from Q3. Key leadership additions included Shawn Myers as VP of Product Management, bringing 15 years of experience building healthcare technology platforms, and Hanna Echols leading data science research and development with two decades of home health and hospice data expertise.
The company also strengthened its advisory board, adding Brendan Farmer alongside existing advisors Gary Voydanoff, Chet Robson, and Jon Warner. This combination of operational leadership and strategic advisors positions IO Health to navigate the complex healthcare technology market.
Looking Ahead to 2026
CEO frames 2026 as a year focused on execution across four key goals: establishing market leadership in compliant documentation, doubling value delivered per patient monthly, growing revenue by 10x, and raising a Series A funding round.
The company plans to attend several major healthcare conferences in early 2026, including HC100, VIVE, and the Capital + Strategy summit. These events provide opportunities to connect with potential customers, partners, and investors as IO Health scales its operations.
The broader vision extends beyond post acute care. While starting in home health and hospice where the founders have deep expertise, IO Health sees opportunities to bring workflow augmentation to other healthcare verticals where clinical judgment remains essential and cannot be automated away.
The Investment Opportunity
For potential investors, IO Health presents an interesting case study in vertical SaaS for healthcare. The company addresses a clear pain point (documentation burden), has demonstrated product market fit through strong retention metrics, and operates in a large and growing market as healthcare shifts toward home based care.
The seed round led by Nina Capital provides runway for growth, but the company is already planning for a Series A raise in mid 2026. They are also exploring alternative funding options including healthcare innovation grants and venture debt to extend their capital efficiency.
The home health and hospice market continues to expand as the population ages and healthcare systems look for ways to reduce costs while improving outcomes. Solutions that help providers operate more efficiently while maintaining compliance become increasingly valuable in this environment.
IO Health's focus on augmenting rather than replacing human workers also positions it well in a market where clinical judgment and human connection remain central to care delivery. By making existing workflows better rather than forcing wholesale changes, the company reduces adoption friction and accelerates time to value for customers.
As healthcare organizations face ongoing workforce challenges and regulatory pressures, tools that help clinicians work more efficiently while ensuring compliance become essential infrastructure. IO Health appears well positioned to capitalize on these trends as it enters 2026 with strong momentum and a clear path toward its Series A milestone.
